MHM: Novel agents, combos show promise for relapsed/refractory CLLOctober 2, 2015Leukemia, Myelodysplasia, Transplantation
MHM: Novel agents, combos show promise for relapsed/refractory CLLOctober 2, 2015Leukemia, Myelodysplasia, Transplantation
Chromosome 3 abnormalities linked to poor CML outcomesOctober 2, 2015Leukemia, Myelodysplasia, Transplantation
Chromosome 3 abnormalities linked to poor CML outcomesOctober 2, 2015Leukemia, Myelodysplasia, Transplantation
Advances in AML understanding could translate to improved therapySeptember 21, 2015Leukemia, Myelodysplasia, Transplantation
HELIOS trial: Ibrutinib safely boosts survival in CLL/SLLSeptember 21, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
No evidence for CLL transmission via blood transfusionSeptember 21, 2015Leukemia, Myelodysplasia, Transplantation
CLL exosomes promote stromal cell transition into cancer-associated fibroblastsSeptember 18, 2015Leukemia, Myelodysplasia, Transplantation
Reovirus ready for clinical testing in CLLSeptember 18, 2015Leukemia, Myelodysplasia, Transplantation
Mutation testing aids CML treatment decisionsSeptember 17, 2015Leukemia, Myelodysplasia, Transplantation
Agent blocks STAT3 protein and might prevent AML relapseSeptember 9, 2015Leukemia, Myelodysplasia, Transplantation
Heme Themes: Transplant timing for myelofibrosis in the era of JAK2 inhibitorsSeptember 3, 2015Leukemia, Myelodysplasia, Transplantation
Heme Themes: Challenges in averting the progression of MPN, MDSSeptember 3, 2015Leukemia, Myelodysplasia, Transplantation
CLL patients achieve remission with CAR-modified T-cellsSeptember 2, 2015Leukemia, Myelodysplasia, Transplantation
Persistent mutations linked to poorer outcomes in AMLAugust 25, 2015Leukemia, Myelodysplasia, Transplantation